BRAF and cancer: In support of this scenario, the expression of the Tn antigen (GalNca-Ser/Thr), a precursor of Gal-GalNc, is elevated in human cancer cells with a BRAF mutation or in colon tissues from BRAFV600E−inducible mouse models (56).